Invention Grant
- Patent Title: Polypeptide and use thereof
-
Application No.: US16295653Application Date: 2019-03-07
-
Publication No.: US11213563B2Publication Date: 2022-01-04
- Inventor: Shuntao Luo , Bo Li , Yong Hou , Xiumei Lin , Ting An
- Applicant: Genoimmune Therapeutics Co., Ltd.
- Applicant Address: CN Hubei
- Assignee: Genoimmune Therapeutics Co., Ltd.
- Current Assignee: Genoimmune Therapeutics Co., Ltd.
- Current Assignee Address: CN Hubei
- Agency: Ice Miller LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574 ; A61K48/00 ; A61M37/00 ; C12N5/00 ; A61K38/08 ; A61P35/00 ; A61K39/00 ; C07K7/06 ; G01N27/62 ; C07K14/78

Abstract:
Provided are a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid, an antigen-presenting cell presenting the polypeptide on the surface of the cell, and immune effector cell thereof, a pharmaceutical composition containing the polypeptide, a vaccine containing the nucleic acid, the nucleic acid construct, the expression vector, the host cell, the antigen-presenting cell, and the immune effector cell, and an antibody recognizing the polypeptide. Also provided is a therapeutic method using the polypeptide, the nucleic acid, the pharmaceutical composition, the vaccine, and the antibody. Also provided are a diagnosis method and diagnosis apparatus for detecting the described polypeptide. Also provided is an application of the polypeptide in preparing a vaccine, a tumor diagnosis kit, or a pharmaceutical composition, and an application of the polypeptide or the nucleic acid as a test target in tumor diagnosis.
Public/Granted literature
- US20190263864A1 POLYPEPTIDE AND USE THEREOF Public/Granted day:2019-08-29
Information query